Table I.
Cell line | MSI status/other relevant alteration | Tumor location, histology | Type of sample |
---|---|---|---|
Colo320 | MSS | Large intestine, carcinoma, adenocarcinoma | Cultured cells |
H1650 | MSS | Lung carcinoma, non-small cell carcinoma | Cultured cells |
H1975 | MSS | Lung, carcinoma, adenocarcinoma | Cultured cells |
HT29 | MSS | Large intestine, carcinoma, NS | Cultured cells |
SW1116 | MSS | Large intestine, carcinoma, adenocarcinoma | Cultured cells |
HCT116 | MSI | Large intestine, carcinoma, NS | Cultured cells |
LoVo | MSI/POLD1 | Large intestine, carcinoma, adenocarcinoma | Cultured cells |
LS174T | MSI | Large intestine, carcinoma, adenocarcinoma | Cultured cells |
RKO | MSI | Large intestine, carcinoma, NS | Cultured cells |
A549 | MSS | Lung, carcinoma, NS | FFPE cells |
H2228 | MSS | Lung, carcinoma, non-small cell carcinoma | FFPE cells |
HCC2998 | MSS/POLE | Large intestine, carcinoma, adenocarcinoma | FFPE cells |
MCF7 | MSS | Breast, carcinoma, NS | FFPE cells |
T47D | MSS | Breast, carcinoma, ductal carcinoma | FFPE cells |
SK-MEL-2 | MSI | Skin, malignant melanoma, NS | FFPE cells |
FFPE, formalin-fixed paraffin-embedded; MSI, microsatellite instability; MSS, microsatellite stability; NS, not specified.